Your browser doesn't support javascript.
loading
Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
Wen, Dacheng; Li, Songhe; Jiang, Weidong; Zhu, Jiaming; Liu, Jingjing; Zhao, Shutao.
Affiliation
  • Wen D; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
  • Li S; Department of Ophthalmology, the First Hospital of Jilin University, Chaoyang District, Changchun 130021, China.
  • Jiang W; Department of Hepatobiliary and Pancreatic Surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
  • Zhu J; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
  • Liu J; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
  • Zhao S; Department of Gastrointestinal nutrition and hernia surgery, the Second Hospital of Jilin University, Nanguan District, Changchun 130041, China.
Biomed Pharmacother ; 167: 115375, 2023 11.
Article in En | MEDLINE | ID: mdl-37802728
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biomed Pharmacother Year: 2023 Document type: Article Affiliation country: Country of publication: